The Risks of Health E-Cigarettes: Safety Concerns Arise

Sep.07.2022
The Risks of Health E-Cigarettes: Safety Concerns Arise
Healthy" e-cigarettes, containing vitamins and oils, are growing in popularity but lack safety testing and may have long-term risks.

The so-called health electronic cigarettes are becoming increasingly popular. Unlike regular electronic cigarettes that contain nicotine, these products contain vitamins or essential oils. However, they have caught the attention of the US Food and Drug Administration (FDA).


Healthy electronic cigarettes, also known as 'nutritional supplement diffusers,' encompass a range of products that share a common source found in electronic cigarettes. Unlike traditional cigarettes, electronic cigarettes deliver nicotine to the lungs without combustion or tobacco. This allows for the removal of harmful ingredients such as tobacco tar. Electronic cigarettes work by utilizing energy from a battery to heat liquid, creating an inhalable vapor.


A new line of products aims to use the same inhalation delivery system for various non-nicotine products, including popular vitamins (such as B12 and C), milk thistle, melatonin (a hormone), green tea, and various essential oils. The health e-cigarette company claims that different combinations of these additives can help improve focus, promote sleep, and even aid in weight loss.


Inhaling rather than swallowing these compounds allows for quicker absorption into the bloodstream, hence theoretically making vitamins and supplements more effective when inhaled.


Many of these additives will be familiar as supplements deemed safe for ingestion. However, most lack inhalation safety testing, particularly in regards to potential long-term harm. Because healthy e-cigarettes do not contain nicotine, they have managed to evade regulatory agencies.


The onset of the 2019 outbreak of e-cigarette or vaping product use associated lung injury (or EVALI) in the United States highlighted the importance of detecting ingestion methods. In the initial report of 60 deaths related to EVALI, vitamin E acetate was identified as a key factor causing lung damage in these individuals. Vitamin E is a common food additive, therefore this clearly emphasizes that even well-known healthy substances can have serious consequences on one's health when inhaled.


These devices are quite innovative in the market, and therefore research on their safety is scarce. Administering incorrect patient groups with untested methods could render many benign or beneficial compounds harmful. For example, the benefits of vitamin C are well-known, but using high doses of vitamin C has been shown to increase the risk of death in sepsis patients.


Vitamin B12 is also a popular additive in these devices. B12 injections are highly effective in restoring vitamin levels for those who are deficient. However, there is no evidence to support any benefits for people with normal B12 levels. Additionally, we lack evidence on the safety or efficacy of inhaling B12.


A research conducted in 1967 revealed that inhaling vitamin B12 showed no benefits compared to injecting supplements. However, even at that time, researchers pointed out the potential risk of lung damage.


We can also examine information on components commonly shared with electronic cigarettes to identify potential impacts. Some products offer Vitamin B12 dissolved in vegetable glycerin, a common ingredient in e-liquids. Other products use propylene glycol or a mixture of two liquids. When heated, these components can break down into harmful chemicals known as reactive carbonyl compounds, such as formaldehyde.


These chemicals have been found to damage alveolar macrophages, which are crucial immune cells in the lungs, in a manner that does not depend on the presence of nicotine. Similar findings have been observed in other important airway and immune cells.


Electronic cigarettes that offer essential oils as a healthier option may also be subject to similar issues. They contain a mixture of compounds known as terpenes, as well as other chemicals similar to those found in e-liquids.


According to reports, terpenes have a range of benefits, including anti-cancer, anti-allergy and antibacterial properties, indicating potential benefits of taking these essential oils. However, terpenes can be degraded by heat and may be broken down into harmful compounds when inhaled, which can irritate the respiratory tract and potentially be toxic to cells at higher doses and longer exposure times.


Due to the similarities between electronic cigarettes and health e-cigarettes, these companies are now facing increasingly strict scrutiny from public health institutions. The FDA warns that health e-cigarettes are "unsafe," "ineffective," and "unproven.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only intended for industry exchange and research.


Due to the limitations of the translator’s skills, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government's stance and statements on any issues related to domestic, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
EU ‘TPD3’ Enters Next Phase on Aug. 14 as Fragmented Vape and Nicotine Pouch Rules Push the Single Market Toward Regulatory Overhaul
A 12-week European Commission consultation on revising the Tobacco Products Directive and Tobacco Advertising Directive is due to close on Aug. 14, 2026. The Commission has identified e-cigarette flavours, disposable vapes, tobacco heating devices, nicotine pouches, nicotine-free e-cigarettes, packaging and digital marketing among areas for possible new EU rules. National regulations already vary significantly across the bloc, a fragmentation the Commission says creates internal-market barriers and distorts competition. No formal revised TPD/TAD legislative text has yet been published, with the Commission currently indicating December 2026 for the legislative initiative.
Aug.14
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria’s second-quarter results show a U.S. nicotine market splitting across price, product and regulation. Smokeable profit rose 2.4% as Marlboro pricing offset lower volumes, while discount brand Basic gained share among value-conscious smokers. In oral nicotine, on! PLUS expanded distribution but faced intensifying competition from ZYN and Velo. NJOY remained off the market as patent and regulatory hurdles delayed its return. The broader lesson: U.S. growth increasingly depends on price-tier strategy, retail execution, authorisation and enforcement readiness across the industry.
Special Report
Jul.31
BAT UK Director Tolga Kilic Says Illicit Nicotine Market Squeezes Legal Retailers Amid Rising Compliance Costs
BAT UK Director Tolga Kilic Says Illicit Nicotine Market Squeezes Legal Retailers Amid Rising Compliance Costs
UK retail publication Grocery Trader has published a viewpoint article from Tolga Kilic, Commercial Director for BAT UK & Ireland, discussing the impact of illicit nicotine products on legitimate retail channels. Kilic said illegal vapes and other illicit nicotine products create competitive pressure for compliant retailers and called for stronger market controls and supply-chain oversight. The comments come as the UK advances policies including the disposable vape ban and Vaping Products Duty, creating a more complex operating environment for legal vape retailers.
Jul.28
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
FTC Scrutinizes Fifty Bar’s “Made in America” Claims as Vape Marketing Faces New Compliance Risk
FTC Scrutinizes Fifty Bar’s “Made in America” Claims as Vape Marketing Faces New Compliance Risk
The Federal Trade Commission sent a warning letter to Lucky Bar Holdings LLC over “Made in the USA” claims tied to Fifty Bar vape products, saying staff had reason to believe the products may be imported in whole or in significant part despite unqualified U.S.-origin marketing claims.
Jul.20